leisure time -WSS

leisure time

author：comprehensive 2025-10-02 22:25:06 - browse：853

Pfizer plans to exit a major biotechnology industry trade association. Cindy Ord/Getty Images for Pfizer/BioNTech

WASHINGTON — Pfizer has decided to leave the Biotechnology Innovation Organization, according to two sources familiar with the planning.

The departure is a blow to BIO, which represents members ranging from small biotech startups to massive pharmaceutical companies. The group on Tuesday announced its new CEO, rare disease advocate and biotech executive John Crowley.

“The economic situation for the industry is difficult indeed and we of course are disappointed that any company would be forced to take a break from its BIO membership. We certainly hope that when economic conditions improve, we can welcome those companies back and welcome new members to join us as well, but it in no way affects our mission of protecting patients and medical innovation in the United States,” said BIO’s Chief Public Affairs and Marketing Officer Rich Masters. Masters said he wouldn’t comment on the status of any particular member.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Change Healthcare: What is it, why does its cyberattack matter?

leisure time

WSS

State of the Union pitch: Bigger Medicare drug price negotiations

STAT Virtual Event: ASCO Recap, Live!

Pregnant women don't need prenatal multivitamins, study concludes

NIH tests clinical research in primary care with $30 million program

5 takeaways from STAT's examination of Zynex Medical

Cheap, fast test for Zika and dengue could cost just $1

leisure time

leisure time

leisure time

The high cost of giving birth even with insurance

Lilly's Alzheimer's drug donanemab backed by FDA advisers

New air purifier tech could be key to improving indoor air quality

Health care court cases: Humana, Sutter, Novant

The high cost of giving birth even with insurance

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Trump demands the U.S. pay no more for drugs than other countries … again

First over

ChatGPT in medicine: STAT answers readers' burning questions

Longer MASH drug regimen improved liver, Akero study finds

explore

He's 19 months old and has one of the world’s rarest diseases

Teladoc has a new CEO, but challenges remain the same

Florida health officials providing scant details on measles cases

He's 19 months old and has one of the world’s rarest diseases

Medicare drug price negotiation hearing pits pharma v Biden admin

'Essentially witchcraft:' A former naturopath takes on the field

knowledge

Wikipedia

leisure time

entertainment